News
FDA asks mRNA vaccine makers to widen age range for rare heart risk warning
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Healthbeat on MSN1h
Trump’s team cited safety in limiting Covid shots. Patients, health advocates see more risk.The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.
Live Science on MSN3d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Zacks Investment Research on MSN2d
MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 ShotsShares of prominent COVID-19 vaccine-makers Moderna MRNA, Pfizer PFE and BioNTech BNTX rose yesterday after the FDA issued new guidance for COVID-19 vaccine boosters. FDA’s New Requirements for ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Health and Me on MSN3d
COVID Cases Rise In US, Trump Administration To Alter Vaccine PolicyThe US Food and Drug Administration (FDA) is featuring an upcoming town hall, set to begin Tuesday at 1 pm in Washington.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback